Discovery of an AIM2 inflammasome inhibitor for the treatment of DNA-driven inflammatory disease (2022)

First Author: Green J
Attributed to:  New insights into NLRP3 within inflammatory disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.07.28.501942

Publication URI: http://dx.doi.org/10.1101/2022.07.28.501942

Type: Preprint